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INTRODUCTION

DIFFERENTIAL DIAGNOSIS

Optic neuritis (ON) is the most common type of
inflammatory, demyelinating disorder of the optic nerve,
most often caused by multiple sclerosis (MS). However,
alternative diagnoses should be considered and
investigated thoroughly in the setting of other systemic
symptoms. Optic neuritis is a rare manifestation of Lyme
disease that typically improves with antibiotics.

The differential diagnosis for her visual complaints and
findings include early disseminated Lyme disease,
neurosyphilis, neurosarcoidosis, perioptic meningioma,
lymphoma, metastatic breast cancer, multiple sclerosis,
acute demyelinating encephalomyelitis, neuromyelitis
optica (NMO), and large vessel vasculitides including
giant cell arteritis.

CASE PRESENTATION

OUTCOME AND FOLLOW-UP

A 50 year-old woman with history of breast cancer
treated with mastectomy and chemotherapy in remission
for ten years presented with a right-sided headache and
right eye vision changes.

The patient underwent a lumbar puncture with an
opening pressure of 11 cm H2O.

She was feeling well until three weeks prior to hospital
admission in June when she developed fevers up to
103.1 °F, sweats, and a circular, slightly raised and pruritic
rash on her neck, chest and on her right lower extremity.
She was evaluated at an urgent care clinic where a rapid
strep test was negative, and she was sent home without
antibiotics. Over the next three days, fevers and rash
resolved without treatment. Two weeks afterward, the
patient developed a right-sided headache associated
with right eye pain and intermittent blurry vision. She
denied neck stiffness, joint pain, rash, or myalgias at that
time. Outpatient ophthalmic evaluation revealed right
optic disc edema and MRI of the brain showed
enhancement along the right optic nerve. The patient
had hiked in wooded areas in the Philadelphia region in
the spring and summer months but was not aware of
any mosquito or tick bites. Her allergies include an
unknown allergy to oxytetracycline.
On admission, she was afebrile and vital signs were
normal. Ophthalmologic exam showed right optic disc
edema and 20/25 visual acuity in both eyes. The left eye
exam and remainder of her physical exam were
unremarkable. Her complete blood count and basic
metabolic panel were normal.
A photograph of the patient’s rash from three weeks
prior demonstrated a flat red patch with central clearing
involving her posterior right thigh.
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The patient had extensive blood and cerebrospinal fluid
testing (CSF) (Tables 1 and 2).
Table 1. Serum studies
BLOOD TESTING

RESULTS

Lyme Disease Antibody

Reactive

Serum Immunoglobulin
M (IgM) Western Blot

Lyme Ab IgM, WB Positive
Lyme 23 kD IgM Reactive
Lyme 39 kD IgM Reactive
Lyme 41 kD IgM Reactive

Serum Immunoglobulin
G (IgG) Western Blot

Lyme Ab IgG, WB Negative
Lyme 18 kD IgG Nonreactive
Lyme 23 kD IgG Reactive
Lyme 28 kD IgG Nonreactive
Lyme 30 kD IgG Nonreactive
Lyme 39 kD IgG Reactive
Lyme 41 kD IgG Reactive
Lyme 45 kD IgG Nonreactive
Lyme 58 kD IgG Nonreactive
Lyme 66 kD IgG Nonreactive
Lyme 93 kD IgG Nonreactive

Rapid Plasma Reagin (RPR) Nonreactive
Quantiferon TB Gold Test

Negative

NMO IgG Antibody

Negative

Table 2. CSF studies
CSF STUDIES

RESULTS (reference range)

Fluid Cell Count

20 Red Blood Cells
2 White Blood Cells

Protein

26 mg/dL (15 - 55)

Glucose

62 mg/dL (40 - 70)

Gram Stain

No organisms seen

Aerobic/Anaerobic Culture

No growth

Venereal Disease Research
Laboratory (VDRL)

Negative

Cryptococcal Antigen

Nonreactive

Lyme polymerase chair
reaction (PCR)

Positive

Angiotensin Converting
Enzyme (ACE) level

8 mcg/L (<=15)

NMO/AQP4-IgG CBA

Negative

Myelin basic protein level

< 2.0 ng/mL (0 - 4)

Oligoclonal Bands

Pathology report: The patient's
CSF contains 2 well defined
gamma restriction bands that
are also present in the patient's
corresponding serum sample,
but some bands in the CSF are
more prominent. This pattern
is associated with GuillainBarre's syndrome, peripheral
neuropathy or increased
permeability of the blood-brain
barrier secondary to infection
or trauma.

Protein Electrophoresis

Normal

Cytology

Negative for malignancy

She was diagnosed with acute optic neuritis secondary
to early disseminated Lyme disease based on positive
serum Lyme disease serologies, recent erythema
migrans rash, epidemiology, and positive CSF Lyme
PCR. The normal CSF levels of angiotensin converting
enzyme (ACE), NMO/Aquaporin-4-IgG antibody, and
myelin basic protein made neurosarcoidosis,
neuromyelitis optica, and multiple sclerosis, less likely.
MRI of the brain and orbits demonstrated asymmetric
e n l a rg e m e nt a n d p e r i n e u r a l ci rcu mfe re nt i a l
enhancement of the right optic nerve from the optic
disc to the right optic canal (Figure 1).

Figure 1. R optic nerve enhancement with asymmetric enlargement of the right
optic nerve/sheath complex from the level of the optic disk where it appears to be
enlarged to the level of the right optic canal and associated with perineural circumferential enhancement of the optic nerve sheath.

She was started on IV ceftriaxone 2 g every 24 hours for
a total of 14 days in conjunction with a short course of
methylprednisolone. She was not treated with
doxycycline given her allergy to oxytetracycline. Her
blurry vision and headache improved significantly and a
follow up MRI of the brain 2 months later showed
resolution of the above findings (Figure 2).

Figure 2. Significant improvement/resolution of abnormal signal and enhancement
of the right optic nerve in keeping with Lyme optic neuritis. No new areas of
abnormal signal or enhancement in the brain or orbits.
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DISCUSSION
Optic neuritis, an inflammatory demyelination of the
optic nerve, causes acute monocular visual loss.
Causative etiologies comprise a broad differential
i n cl u d i n g m u lt i p l e s cl e ro s i s , s y s te m i c l u p u s
erythematosus, infection (Lyme disease, toxoplasmosis,
Bartonella henselae, Mycobacterium tuberculosis, human
immunodeficiency virus, West Nile virus, parvovirus B19,
and some Herpes viruses) and neoplasms. Prompt
diagnosis of infectious causes allows for timely antibiotic
administration and potential reversal of the vision loss.
Lyme disease is a multisystem infection with the nervous
system involved in 10 to 15 percent of infected individuals.
The spirochete Borrelia burgdorferi is carried by the
Ixodes tick. Following a bite from the tick, the spirochete
first invades locally and then disseminates hematogenously to various organs including the central and
peripheral nervous systems1 . Lymphocytic meningitis,
cranial neuropathy (most commonly facial nerve palsy),
and radiculoneuritis form the classic triad of acute early
neurologic Lyme disease. Ocular complications of Lyme
disease include conjunctivitis, keratitis, extra-ocular
muscle palsies, and acute optic neuritis2 .
Cranial neuropathies and radiculoneuritis are thought to
share similar neurophysiologic patterns of a multifocal,
patchy inflammatory process affecting the peripheral
nerve, namely a mononeuritis multiplex3 . However, it has
been more challenging to describe the pathophysiology
of optic neuritis; the optic nerve function resembles
central nervous system (CNS) function similar to
parenchymal brain involvement. Rupprecht et al.
postulate that local immune cells secrete cytokines in
response to spirochete presence in the CNS, which
directly injures neurons and leads to the lymphocytic
pleocytosis seen in the CSF5 .
A number of factors make establishing a causal
relationship between optic neuritis and Lyme disease
challenging. The incidence of optic neuritis attributable
to Lyme is low, even in Lyme-endemic regions.
Asymptomatic seropositivity to B. burgdorferi (false
positive or prior infection) in endemic areas further
complicates the diagnosis. In a retrospective analysis of
Lyme serologies in 440 patients with optic neuritis,
Sibony et al. defined a rigorous set of criteria and, applying
these, found only a strong causal link between Lyme
disease and papillitis and posterior uveitis but not with
optic neuritis. According to their criteria, definitive proof
of a causal link requires identification of organism by
culture or tissue histology from the CSF or optic nerve in
a patient with clinically active Lyme disease and optic
neuritis. To meet criteria for the next category, labeled
“strong evidence”, patients must have optic neuritis,
endemic exposure, exclusion of syphilis and multiple
sclerosis, and a positive serum Lyme titer in association
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with at least one of the following: 1) encephalitis or
meningitis with CSF pleocytosis, intrathecal antibody
production, or CSF PCR positive for B. burgdorferi DNA,
and a positive Western blot; 2) recent erythema migrans;
and 3) recent signs of Lyme disease, such as facial nerve
palsy, arthritis, or radiculoneuritis with positive serum
ELISA confirmed by Western blot4. This patient meets the
criteria to suggest strong evidence for causality between
her optic neuritis and Lyme disease. Review of the
literature revealed no cases that definitively demonstrated
causation, based on the criteria above, of Lyme optic
neuritis.
Most patients described with symptoms and studies
concerning for Lyme optic neuritis responded to
antibiotics with good outcomes 4,6-8 . Differences exist
between European, which rely on oral doxycycline, and
the United States’ guidelines for management of
Neuroborreliosis 9 . In the United States, the 2006
Infectious Disease Society of America guidelines only
recommend oral doxycycline for patients with isolated
facial nerve palsy without abnormal CSF findings,
meningitis, or radiculoneuritis. Intravenous ceftriaxone,
cefotaxime, or penicillin G is recommended when
abnormal CSF findings are present 10. Ceftriaxone was the
treatment used for most of the reported Lyme optic
neuritis cases. The role of adjunctive corticosteroids
remains unclear11 .
In conclusion, optic neuritis due to Lyme disease remains
difficult to prove. Herein we presented a case of a patient
with epidemiology and clinical features consistent with
recent Lyme infection with subjective and objective visual
abnormalities that developed a few weeks later. CSF and
serum studies for Borrelial antibodies and DNA
demonstrated, at a minimum, presence of spirochetes in
the CNS. Short of direct visualization of organisms in the
optic nerve and in the absence of an alternative diagnosis,
these studies suggest strong evidence for causation.

KEY POINTS
• It is important to consider Lyme disease in the
differential diagnosis in patients from Lyme endemic
areas who present with optic neuritis.
• Most patients with probable Lyme optic neuritis
respond favorably to IV ceftriaxone but the role of
corticosteroids remains controversial.
• There is need for more specific diagnostics to prove
Borrelial involvement of the optic nerve

REFERENCES
1. Rizzoli A, Hauffe H, Carpi G, et al. Lyme borreliosis in Europe.
Euro Surveill 2011; 16:1-8.
2. Lesser, R.L. Ocular manifestations of Lyme disease. Am J Med.
1995;98:60S–62S.
3. Halperin JJ. Nervous system Lyme disease: is there a controversy?
Semin Neurol 2011; 31:317-324.
4. Sibony P, Halperin J, Coyle PK, Patel K. Reactive Lyme serology in optic
neuritis. Journal of Neuro-Ophthalmology 2005; 25(2):71-82.
5. Rupprecht TA, Koedel U, Fingerle V, Pfister HW. The pathogenesis of
Lyme neuroborreliosis: from infection to inflammation. Mol Med 2008;
14:205-212.
6. Jacobson DM. Lyme disease and optic neuritis: long-term follow-up of
seropositive patients. Neurology 2003; 60(5):881-2.
7. Krim E, Guehl D, Burbaud P, Lagueny A. Retrobulbar optic neuritis: a
complication of Lyme disease? J Neurol Neurosurg Psychiatry 2007;
78(12):1409-10.
8. Rothermel H, Hedges 3rd TR, Steere AC. Optic neuropathy in children with
Lyme disease. Pediatrics 2001; 108(2):477-81.
9. Karlsson M, hammers-Berggren S, Lindquist L, et al. Comparison of
intravenous penicillin G and oral doxycycline for treatment of Lyme
neuroborreliosis. Neurology 1994; 44:1203.
10. Wormser GP, Dattwyler RJ, Shapiro Ed, et al. The clinical assessment,
treatment, and prevention of lyme disease, human granulocytic
anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious
Disease Society of America. Clin Infect Dis 2006; 43:1089.
11. Blanc F., Ballonzoli L., Marcel C., De Martino S., Jaulhac B., de Seze J., Lyme
optic neuritis. Journal of the Neurological Sciences 2010; 295(1): 117-119.

Anita Modi, MD

The Medicine Forum, Volume 18 | 37 5

